Pharmacy News

July 2018
WSI recently partnered with Cordant Health Solutions to assist in the coordination of medication monitoring for injured workers on chronic opioid therapy.
December 2017
WSI offers several options for a prescribing provider to submit a request for medications, which require prior authorization.
May 2016
WSI recently published a new medical policy, Chronic Opioid Therapy. This policy is a result of the 2015 North Dakota Legislative Assembly amending North Dakota Century Code (N.D.C.C.) § 65-05-39 to address chronic opioid therapy.
July 2015
On August 1, 2015, WSI will utilize US Script®, to provide the same point-of-sale transactions currently in place with tmesys®.
January 2015
Effective February 1, 2015, WSI will require prior authorization of long-acting opioid medication.
October 2013
On November 1, 2013, WSI will utilize PMSI® d.b.a. tmesys®, to provide the same point-of-sale transactions currently in place with US Script®.
May 2013
On April 17, 2013 Oxycontin was scheduled to go off the patent protection and become available for the generic marketplace.